Today's Pre-Market Stock Movers: BMY, ADBE, MSTR, AZN and More

$Clovis Oncology(CLVS.US)$ +11.3%, $Cardiff Oncology(CRDF.US)$ +9%, $Immatics(IMTX.US)$ +8.3%, $IDEAYA Biosciences(IDYA.US)$ +8%, $Lyra Therapeutics(LYRA.US)$ +5.7%, $POINT Biopharma(PNT.US)$ +5.7%, $Edgewise Therapeutics(EWTX.US)$ +4.7%, $Concert Pharmaceuticals(CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals(DCPH.US)$ +3.2%, $Veracyte(VCYT.US)$ +2.6%, $SpringWorks Therapeutics(SWTX.US)$ +2.3%, $I-Mab(IMAB.US)$ +2.3%, $Puma Biotechnology(PBYI.US)$ +1.8%, $AstraZeneca(AZN.US)$ +1.1%, $BeiGene(BGNE.US)$+0.8%.

$Spectrum Pharmaceuticals(SPPI.US)$ +15.8% (receives FDA approval for R.OLVEDON injection; expects to launch product in Q4)

$XL Fleet(XL.US)$ +5.1% (completes transformational acquisition of Spruce Power)

$Enthusiast Gaming(EGLX.US)$ +4.7% (signed a media sponsorship deal with Hulu + Live TV the premium streaming destination as the first official media sponsor of NFL Tuesday Night Gaming)

$Centessa Pharmaceuticals(CNTA.US)$ +4.5% (Announces Non-Human Primate Pharmacokinetic and Safety Data for LB101)

$Fortuna Silver Mines(FSM.US)$ +2.8% (extends gold mineralization at Sunbird and identifies new regional prospects at Sgula)

$ACADIA Pharmaceuticals(ACAD.US)$ +2.6% (receives acceptance from FDA for NDA of Trofinetide)

$Occidental Petroleum(OXY.US)$ +1.7% (Berkshire Hathaway discloses 26.8% stake up from 20.28% previously)

$Life Time(LTH.US)$ +1.4% (closes on $200 million in sale-leaseback transactions)

$Chicken Soup for the Soul Entertainment(CSSE.US)$ +1% (files for 7745453 share common stock offering by selling shareholders relates to warrants)

$Apexigen(APGN.US)$ -8%, $Lyell Immunopharma(LYEL.US)$ -4.9%, $Amgen(AMGN.US)$ -4%, $ImmunoGen(IMGN.US)$ -2%

$Relay Therapeutics(RLAY.US)$ -8% (announces underwritten offering of $300 mln in common stock)

$Vroom(VRM.US)$ -2.8% (files for $300 mln mixed securities shelf offering)

$Madison Square Garden Sports(MSGS.US)$ -2.4% (President and CEO to step down at end of year; also names David Hopkinson as COOZ effective immediately)

$A10 Networks(ATEN.US)$ -2.3% (purchased an aggregate of 3.5 mln of its shares from Summit)

$Allakos(ALLK.US)$ -2.2% (Initiation of Phase 2b Clinical Trial of Subcutaneous Lirentelimab in Chronic Spontaneous Urticaria)